Frankfurt
06.08.26 | 08:02
0,142 Euro
+0,71 % +0,001
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.06. | VEXT Science, Inc.: Vext Opens Sixth Ohio Dispensary in Fairfield | 472 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with operations in Arizona... ► Artikel lesen | |
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 21.05. | Vext Science reports Q1 results | 4 | Seeking Alpha | ||
| 21.05. | VEXT Science, Inc.: Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales | 816 | Newsfile | Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million.Operating cash flow of $1.6 million... ► Artikel lesen | |
| 15.05. | Vext Science Inc: Vext Science hires Zuanic & Associates for IR | 2 | Stockwatch | ||
| 15.05. | VEXT Science, Inc.: Vext Engages Zuanic & Associates | 541 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and... ► Artikel lesen | |
| 14.05. | VEXT Science, Inc.: Vext Announces Date for Q1 2026 Financial Results Release | 631 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced... ► Artikel lesen | |
| 30.04. | Vext Science reports Q4 results | 1 | Seeking Alpha | ||
| 29.04. | VEXT Science, Inc.: Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales | 366 | Newsfile | Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million)... ► Artikel lesen | |
| 22.04. | Vext Science Inc: Vext revises 2025 results release date to April 29 | 1 | Stockwatch | ||
| 21.04. | VEXT Science, Inc.: Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release | 428 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today... ► Artikel lesen | |
| 30.03. | Vext Science Inc: Vext to discontinue operations at Arizona facility | 1 | Stockwatch | ||
| 30.03. | VEXT Science, Inc.: Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion | 1.181 | Newsfile | Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow.Proceeds from the sale to facilitate debt reduction, with key... ► Artikel lesen | |
| 04.03. | Vext Science Inc: Vext receives licence for seventh dispensary in Ohio | 4 | Stockwatch | ||
| 03.03. | VEXT Science, Inc.: Vext Advances Ohio Expansion with Seventh Retail Location | 494 | Newsfile | Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals.Marks Vext's seventh dispensary in Ohio, and second in... ► Artikel lesen | |
| 11.12.25 | VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting | 519 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 20.11.25 | VEXT Science, Inc.: Vext Reports Q3 2025 Financial Results | 1.261 | Newsfile | Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations... ► Artikel lesen | |
| 11.11.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2025 on November 20, 2025 | 457 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 17.09.25 | VEXT Science, Inc.: Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer | 465 | Newsfile | Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and... ► Artikel lesen | |
| 20.08.25 | VEXT Science, Inc.: Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin | 645 | Newsfile | Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona.Revenue of $13.4 million, up 59%... ► Artikel lesen | |
| 11.08.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2025 on August 20, 2025 | 524 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,574 | +2,63 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2027 First Quarter Results | NASDAQ | TSX: ACB
Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue
Safari Flower Company Receives Three-Year EU-GMP... ► Artikel lesen | |
| CANOPY GROWTH | 0,820 | +2,58 % | Canopy Growth Q1 preview: Another loss-making quarter before EBITDA turnaround | ||
| TILRAY BRANDS | 3,900 | +1,69 % | Tilray-Aktie: Startet jetzt die 700%-Chance? | Die Tilray-Aktie hat in den vergangenen Tagen eine bemerkenswerte Kehrtwende vollzogen. Nach enttäuschenden Quartalszahlen am 28. Juli geriet der Cannabis-Titel zunächst unter Druck, ehe bereits einen... ► Artikel lesen | |
| INNOCAN PHARMA | 1,500 | +3,45 % | Innocan Pharma Corporation: Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust | Milestone underscores strong consumer confidence, exceptional product quality, and the Company's expanding presence in the U.S. consumer wellness marketHERZLIYA, Israel and CALGARY, Alberta... ► Artikel lesen | |
| CRONOS GROUP | 2,674 | +13,31 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 1,140 | +3,83 % | EQS-Adhoc: SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung von Insolvenzverfahren zu stellen | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Strategische Unternehmensentscheidung/Insolvenz
SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | -45,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,837 | 0,00 % | Organigram Global Inc: Organigram Global to release fiscal Q3 results Aug. 11 | ||
| GREEN THUMB INDUSTRIES | 5,970 | +2,40 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,034 | -0,96 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,617 | +9,59 % | Cresco Labs Q2 2026 slides: cannabis re-rating thesis meets skepticism | ||
| NOVERIS HEALTH SCIENCES | 0,324 | -46,45 % | Noveris Health Sciences Inc.: Noveris Health Sciences Inc. Unaware of Any Material Change | Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,592 | +10,86 % | Quantum BioPharma Announces Closing of Debt Settlement | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 30, 2026... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,970 | +6,59 % | Happy Belly Food Group Inc.: Happy Belly Food Group Promotes Ian Thomas to Chief Financial Officer as Franchising Growth Continues to Accelerate | Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands... ► Artikel lesen | |
| COMPASS PATHWAYS | 11,700 | -0,85 % | Compass Pathfinder Limited: Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026 | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord... ► Artikel lesen |
Das Unternehmen VEXT SCIENCE INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,71 % bei einem Aktienkurs von 0,142 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.